Abstract
Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Volume: 10 Issue: 2
Author(s): Pasquale Niscola, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Michele Ferrannini, Gregorio Antonio Brunetti, Francesco Bondanini, Roberto Palumbo, Alessio Perrotti, Claudio Romani, Claudio Cartoni, Fabio Efficace and Paolo de Fabritiis
Affiliation:
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Abstract: Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Export Options
About this article
Cite this article as:
Niscola Pasquale, Tendas Andrea, Giovannini Marco, Scaramucci Laura, Cupelli Luca, Ferrannini Michele, Antonio Brunetti Gregorio, Bondanini Francesco, Palumbo Roberto, Perrotti Alessio, Romani Claudio, Cartoni Claudio, Efficace Fabio and de Fabritiis Paolo, Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses, Cardiovascular & Hematological Agents in Medicinal Chemistry 2012; 10 (2) . https://dx.doi.org/10.2174/187152512800388902
DOI https://dx.doi.org/10.2174/187152512800388902 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nocturnal Blood Pressure Abnormalities in Obstructive Sleep Apnea - Clinical Predictors
Current Respiratory Medicine Reviews Cytoprotective and Antiproliferative Effects of HMG-CoA Reductase Inhibitors
Current Enzyme Inhibition Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
Current Stem Cell Research & Therapy Selective Serotonin Reuptake Inhibitors for Premature Ejaculation: Review of Erectile and Ejaculatory Side Effects
Current Drug Safety Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Alcoholisms Evolutionary and Cultural Origins
Current Drug Abuse Reviews A Quantitative Structure-Activity Relationship Study on Some Series of Potassium Channel Blockers
Medicinal Chemistry Recent Advances in Ozonation of Vegetable Oils
Recent Patents on Materials Science Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Targeting Myocardial Metabolism for the Treatment of Stable Angina
Current Pharmaceutical Design Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Current Molecular Medicine Long Non-coding RNAs in Heart Failure: A Deep Belief Network Based Cluster Analysis
Current Bioinformatics Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs
Current Medicinal Chemistry Radiopharmaceutical Applications of Organometallic Technetium and Rhenium Complexes
Current Inorganic Chemistry (Discontinued) Brutons Tyrosine Kinase as a New Therapeutic Target
Anti-Cancer Agents in Medicinal Chemistry Open Access High Throughput Drug Discovery in the Public Domain: A Mount Everest in the Making
Current Pharmaceutical Biotechnology Treatment Strategies for Fatty Liver Diseases
Reviews on Recent Clinical Trials Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention
Current Molecular Pharmacology